HS

H. Michael Shepard

HA Halozyme: 28 patents #3 of 45Top 7%
Genentech: 11 patents #260 of 2,392Top 15%
C( Celmed Oncology (Usa): 6 patents #1 of 8Top 15%
NE Newbiotics: 5 patents #1 of 3Top 35%
CA Canji: 5 patents #5 of 50Top 10%
University of California: 2 patents #4,561 of 18,278Top 25%
US US Dept of Health & Human Services: 1 patents #1,144 of 3,044Top 40%
GE Genzyme: 1 patents #498 of 891Top 60%
NI NIH: 1 patents #22 of 259Top 9%
Northwestern University: 1 patents #1,629 of 3,846Top 45%
SS Salk Institute For Biological Studies: 1 patents #291 of 521Top 60%
Overall (All Time): #40,895 of 4,157,543Top 1%
58
Patents All Time

Issued Patents All Time

Showing 25 most recent of 58 patents

Patent #TitleCo-InventorsDate
12371685 PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof Ge Wei, Qiping Zhao, Robert James Connor 2025-07-29
12264345 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2025-04-01
12195773 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2025-01-14
12152262 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-11-26
12123035 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-10-22
12110520 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-10-08
12104184 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-10-01
12104185 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-10-01
12091692 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-09-17
12077791 PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-09-03
12060590 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-08-13
12054758 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-08-06
12049652 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-07-30
12037618 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-07-16
12018298 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-06-25
11952600 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2024-04-09
11584923 Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same Christopher D. Thanos, Lin Wang 2023-02-21
11414489 Combination therapy with a hyaluronan-degrading enzyme and an immune checkpoint inhibitor Sanna ROSENGREN, Curtis B. Thompson 2022-08-16
11066656 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2021-07-20
11041149 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2021-06-22
10865400 PH20 polypeptide variants, formulations and uses thereof Ge Wei, Qiping Zhao, Robert James Connor 2020-12-15
10137104 Combination therapy with an anti-hyaluronan agent and therapeutic agent Daniel C. Maneval, Curtis B. Thompson 2018-11-27
9969998 Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same Christopher D. Thanos, Lin Wang 2018-05-15
9913822 Combination therapy with an anti-hyaluronan agent and therapeutic agent Daniel C. Maneval, Curtis B. Thompson 2018-03-13
9458442 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof Ping Jiang, Lei Huang 2016-10-04